Company intelligence / Profile preview

Z-Medica

Wallingford, Connecticut, United Statesquikclot.com ↗

Ownership: Private
Employees: ~434
Development stage: Commercial

Overview

QuikClot products are FDA-cleared and CE-marked commercial devices for rapid hemorrhage control. They are widely adopted by the US military as first-line treatment for traumatic bleeding and used globally in hospitals, emergency response, law enforcement, and military settings. Clinical studies have demonstrated their effectiveness in accelerating clot formation and improving patient outcomes.

Therapeutic areas: CardiovascularHematology
Modalities: Device (Hemostatic device)Biologic (kaolin-based hemostatic agent)
Industry: Consumable Medical Devices

Drug pipeline

3 assets

QuikClot

Commercial

Indications: Hemorrhage control

2 more assets in the full pipeline.

Request access →

Partnerships

Stöpler Instrumenten & Apparaten B.V. (Netherlands distribution)

Beyond the preview

Go deeper on Z-Medica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Z-Medica.

Explore the full profile